Lantheus Holdings (LNTH) Current Assets (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Current Assets came in at $942.3 million in Q1 2026, down 33.82% year-on-year from $1.4 billion in Q1 2025, and up 4.7% on a QoQ basis from $900.0 million in Q4 2025.
Lantheus Holdings (LNTH) Current Assets (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Current Assets data on file, last reported at $942.3 million in Q1 2026.
- On a quarterly basis, Current Assets fell 33.82% year-over-year to $942.3 million in Q1 2026; TTM through Mar 2026 was $942.3 million, a 33.82% decrease from a year earlier, with the FY2025 full-year figure at $900.0 million, down 32.16% from the prior year.
- Current Assets for Q1 2026 stood at $942.3 million, up from $900.0 million in the prior quarter.
- Over the last five years, Current Assets for LNTH reached as high as $1.4 billion in Q1 2025 and fell as low as $324.7 million in Q1 2022.
- Historically, Current Assets has averaged $933.2 million across 5 years, with a median of $942.3 million in 2026.
- Across the five-year window, Current Assets surged 187.38% in 2022 and tumbled 33.82% in 2026, its largest moves.
- Year by year, Current Assets stood at $677.6 million in 2022, then surged by 60.24% to $1.1 billion in 2023, then grew by 22.18% to $1.3 billion in 2024, then tumbled by 32.16% to $900.0 million in 2025, then climbed by 4.7% to $942.3 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $942.3 million in Q1 2026, $900.0 million in Q4 2025, and $925.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 942.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 942.29 Mn |
| Dec 31, 2025 | 899.96 Mn |
| Sep 30, 2025 | 925.09 Mn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.23 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 948.44 Mn |
| Jun 30, 2023 | 752.22 Mn |
| Mar 31, 2023 | 773.27 Mn |
| Dec 31, 2022 | 677.62 Mn |
| Sep 30, 2022 | 501.90 Mn |
| Jun 30, 2022 | 404.42 Mn |
| Mar 31, 2022 | 324.75 Mn |
| Dec 31, 2021 | 235.79 Mn |
| Sep 30, 2021 | 201.52 Mn |
| Jun 30, 2021 | 186.21 Mn |